Indication
Recurrent Urinary Tract Infection
3 clinical trials
4 products
Product
Saccharomyces BoulardiiClinical trial
A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract InfectionsStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Intravesical Gentamicin to Prevent Recurrent UTIStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Product
GentamicinProduct
NitrofurantoinClinical trial
Protocol 19-01: Canadian, Single Centre, Pilot, Open Label Study to Evaluate the Efficacy and Safety of the Bacterial Vaccine Uromune in Treating Recurrent Urinary Tract Infections in Women.Status: Terminated, Estimated PCD: 2022-10-31
Product
Uromune